Aditoprim is an antibacterial dihydrofolate reductase inhibitor. It is currently being investigated for veterinary use, mostly in China for the treatment of various Streptococcus caused conditions. A 2025 study found that it is toxic to the human gut microbiota as most antibiotics are, and established a microbiologically acceptable daily intake of 91.67 µg/kg.BW/day.
References